The upregulated expression of RRBP1 in lung cancer, colorectal cancer, endometrial endometrioid adenocarcinoma, ovarian, breast, and bladder cancer leads to poor prognosis [22,26,29,30,35,40]. Here, RRBP1 is linked to urinary bladder cancer.